CatalYm Updates Leadership to Boost Visugromab Trials
September 15, 2025
Experienced executives, Clinton Musil, Sujata Rao, MD, Heike Krupka, PhD, and Andrea Goddard join CatalYm to broaden and accelerate clinical programs into late-stage development CatalYm,